François-Emery Cotté

Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis

Matteo Giaj Levra, François-Emery Cotté, R. Corre et al. · Lung Cancer · 2019 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia

R Fourcade, François Lacoin, Morgan Rouprêt et al. · World Journal of Urology · 2011 · 102 citations · Full text

Medicine, Internal Medicine, Urology +15

Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin

Tereza Lanitis, François-Emery Cotté, Anne-Françoise Gaudin et al. · Journal of Medical Economics · 2014 · 70 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation

Éric Van Ganse, Nicolas Danchin, Isabelle Mahé et al. · Stroke · 2020 · 66 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European Countries

François-Emery Cotté, H. Benhaddi, I Duprat-Lomon et al. · Clinical Therapeutics · 2014 · 64 citations

Medicine, Cardiology, Pharmacotherapy +17